Zealand Pharma Announces Augmentation of its Management Team as it Continues its Growth Strategy
10-Mar-2010 -
Zealand Pharma A/S announced that Dr. Christian Grøndahl has been appointed Chief Scientific Officer, Mr. Mats Blom as Chief Financial Officer and Dr. John Hyttel as Senior Vice President for Operations.
Dr. Grøndahl, who will take up his duties as CSO April 1, 2010, has a DVM, PhD and DMedSci, ...
Biovitrum
Novo Nordisk
regulatory affairs
+1